Company Filing History:
Years Active: 2015
Title: Pu-Ping Lu: Innovator in Cardiac Treatment
Introduction
Pu-Ping Lu is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of medicine, particularly in the treatment of heart diseases. His innovative work focuses on developing compounds that can aid in the management of hypertrophic cardiomyopathy (HCM).
Latest Patents
Pu-Ping Lu holds a patent for cycloalkyl-substituted pyrimidinedione compounds. This invention provides novel compounds that are useful for treating hypertrophic cardiomyopathy and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The patent details the synthesis and characterization of these compounds, as well as methods for treating HCM and other forms of heart disease.
Career Highlights
Lu is currently associated with Myokardia, Inc., a company dedicated to transforming the treatment of serious cardiovascular diseases. His work at Myokardia has been instrumental in advancing therapeutic options for patients suffering from heart conditions.
Collaborations
Throughout his career, Pu-Ping Lu has collaborated with esteemed colleagues, including Johan D Oslob and Robert G Anderson. These collaborations have further enriched his research and development efforts in the field of cardiac treatment.
Conclusion
Pu-Ping Lu's innovative contributions to cardiac treatment exemplify the impact of dedicated research and development in medicine. His work continues to pave the way for advancements in the management of heart diseases.